ESC Professional Premium Access

The real-world effectiveness and safety of edoxaban treatment in 27,333 Global ETNA-AF programme patients with and without a history of heart failure

Congress Session

About the speaker

Associate Professor Jolanta Siller-Matula

Medical University of Vienna, Vienna (Austria)
1 presentation
0 follower

4 more presentations in this session

Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: a nationwide cohort study

Speaker: Mr M. Grymonprez (Ghent, BE)

Thumbnail

Oral anticoagulation in patients with atrial fibrillation and stage IV and V chronic kidney disease: a systematic review and meta-analysis

Speaker: Doctor A. Miranda-Arboleda (Medellin, CO)

Thumbnail

Potentially inappropriate prescribing and its demographic and clinical correlates in older adults with atrial fibrillation: a population-based study

Speaker: Ms C. Amrouch (Ghent, BE)

Thumbnail

The effect of eplerenone on the disease onset and progression of phospholamban cardiomyopathy in presymptomatic mutation carriers: results of the i-PHORECAST trial

Speaker: Mr R. De Brouwer (Groningen, NL)

Thumbnail

Access the full session

Anticoagulant therapy: real world use and clinical challenges

Speakers: Associate Professor J. Siller-Matula, Mr M. Grymonprez, Doctor A. Miranda-Arboleda, Ms C. Amrouch, Mr R. De Brouwer
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk